Keyphrases
Uveal Melanoma
100%
Melanoma Patients
53%
Metastatic Uveal Melanoma
51%
Metastatic Disease
37%
Metastasis
33%
BRCA1-associated Protein 1 (BAP1)
29%
Melanoma Metastasis
27%
Iris Melanoma
25%
Uvea
21%
Ocular Melanoma
21%
BAP1 mutation
20%
SF3B1
19%
Chromosome 3
19%
Multiplex Ligation-dependent Probe Amplification
19%
Iris
17%
Genetic Background
17%
Melanocytic Tumor of Uncertain Malignant Potential
17%
Polyploid
17%
Dendritic Cell Vaccine
17%
Overall Survival
17%
Multimodality Analysis
17%
Survival Prediction
17%
Aberrant Methylation
17%
Patient Identification
17%
In Situ Hybridization
17%
MicroRNA Expression
17%
Intraocular Pressure
17%
Melanoma
17%
Conjunctival Melanoma
17%
Patients at Risk
17%
Genetic Inheritance
17%
Genetic Testing
17%
EIF1AX
17%
Copy number Variation
15%
Epigenetic Modification
14%
GNA11
14%
SNP Array
13%
Tumor
13%
Chromosome 8
11%
Iris Nevus
9%
Disease-free Survival
8%
Promoter Genes
8%
Variation Pattern
8%
Posterior Uveal Melanoma
8%
TERT Promoter
8%
Gene mutation
8%
Metastatic Melanoma
6%
Prostaglandins
6%
Pilocarpine
6%
Histopathological Data
5%
Mutational Status
5%
Array Data
5%
Medicine and Dentistry
Uveal Melanoma
67%
Metastatic Uvea Melanoma
51%
Metastatic Carcinoma
42%
Nodular Melanoma
35%
Metastatic Melanoma
27%
Iris
23%
Eye Melanoma
18%
Fluorescence in Situ Hybridization
18%
Chromosome 3
17%
Dendritic Cell
17%
Overall Survival
17%
Methylation
17%
microRNA
17%
Melanocytic Tumor
17%
Genetic Background
17%
Multiplex Ligation Dependent Probe Amplification
17%
Intraocular Pressure
17%
Drug Therapy
17%
Chromosome 8
11%
Gene Mutation
8%
Epigenetic Modification
7%
Nevus Sebaceous
7%
Neoplasm
6%
Pilocarpine
6%
Prostaglandin
6%
Promoter Region
5%
Uvea
5%
Biochemistry, Genetics and Molecular Biology
BAP1
36%
SF3B1
20%
Chromosome 3
19%
Fluorescence in Situ Hybridization
19%
Multiplex Ligation-Dependent Probe Amplification
19%
Polyploid
17%
Survival Prediction
17%
MicroRNA
17%
Copy-Number Variation
17%
Methylation
17%
Single-Nucleotide Polymorphism
16%
Epigenetic Modification
12%
Epigenetics
12%
Chromosome 8
11%
Disease Free Survival
10%